Bridgeway Capital Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,600
Closed -$76K 1393
2022
Q1
$76K Buy
3,600
+1,433
+66% +$30.3K ﹤0.01% 1276
2021
Q4
$130K Buy
+2,167
New +$130K ﹤0.01% 1200